A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model

Fertility and Sterility

Volumn 93, Issue 8, 2010, Pages 2674-2679

  Machado, Daniel Escorsim ^a   Berardo, Plínio Tostes ^a   Landgraf, Richardt Gama ^b   Fernandes, Patrícia Dias ^a   Palmero, Celia ^a   Alves, Leandro Miranda ^a   Abrao, Maurício Simões ^c   Nasciutti, Luiz Eurico ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiogenesis; COX 2 inhibitor; endometriosis; PGE2; vascularization; VEGF

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; PARECOXIB; PROSTAGLANDIN E2; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; ATROPHY; CELL ACTIVATION; CELL COUNT; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; GENE EXPRESSION; GENE FUNCTION; HISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

ANGIOGENESIS INHIBITORS; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; ISOXAZOLES; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77952321828     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.11.037     Document Type: Article

References (39)

1. Wheeler J.M. Epidemiology and prevalence of endometriosis. Infertil Reprod Med Clin North Am 3 (1992) 545-549
2. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-469
3. Donnez J., Smoes P., Gillerot S., Casanas-Roux F., and Nisolle M. Vascular endothelial growth factor in endometriosis. Hum Reprod 13 (1998) 1686-1690
4. Wu M.H., Shoji Y., Chuang P.C., and Tsai S.J. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med 9 (2007) 1-20
5. Laschke M.W., and Menger M.D. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 13 (2007) 331-342
6. Podgaec S., Abrao M.S., Dias Jr. J.A., Rizzo L.V., Oliveira R.M., and Baracat E.C. Endometriosis: an inflammatory disease with a Th2 immune response component. Hum Reprod 22 (2007) 1373-1379
7. Gazvani R., and Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 123 (2002) 217-226
8. Pupo-Nogueira A., Oliveira R.M., Petta C.A., Podgaec S., Dias Jr. J.A., and Abrao M.S. Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis. Int J Gynaecol Obstet 99 (2007) 33-37
9. Sales K.J., and Jabbour H.N. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 126 (2003) 559-567
10. Hayes E.C., and Rock J.A. COX-2 inhibitors and their role in gynecology. Obstet Gynecol Surv 57 (2002) 768-780
11. Kirkpatrick K., Ogunkolade W., Elkak A., Bustin S., Jenkins P., Ghilchik M., et al. The mRNA expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin 18 (2002) 237-241
12. Chishima F., Hayakawa S., Sugita K., Kinukawa N., Aleemuzzaman S., Nemoto N., et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 48 (2002) 50-56
13. Cobellis L., Razzi S., De Simone S., Sartini A., Fava A., Danero S., et al. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis. Eur J Obstet Gynecol Reprod Biol 116 (2004) 100-102
14. Ota H., Igarashi S., Sasaki M., and Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16 (2001) 561-566
15. Matsuzaki S., Canis M., Pouly J.L., Wattiez A., Okamura K., and Mage G. Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium. Fertil Steril 82 (2004) 1309-1315
16. Masferrer J.L., Leahy K.M., Koki A.T., Zweifel B.S., Settle S.L., Woerner B.M., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60 (2000) 1306-1311
17. Matsuzaki S., Canis M., Darcha C., Dallel R., Okamura K., and Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 82 (2004) 1609-1615
18. Dogan E., Saygili U., Posaci C., Tuna B., Caliskan S., Altunyurt S., et al. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 82 (2004) 1115-1120
19. Vernon M.W., and Wilson E.A. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44 (1985) 684-694
20. Machado D.E., Abrao M.S., Berardo P.T., Takiya C.M., and Nasciutti L.E. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 90 (2008) 148-155
21. Nap A.W., Griffioen A.W., Dunselman G.A., Bouma-Ter Steege J.C., Thijssen V.L., Evers J.L., et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 89 (2004) 1089-1095
22. Zenclussen A.C., Gerlof K., Zenclussen M.L., Sollwedel A., Bertoja A.Z., Ritter T., et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion. Adoptive transfer of pregnancy-induced CD4 + CD25 + T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 116 (2005) 811-822
23. Wang W., Lin Y., Zeng S., and Li D.-J. Improvement of fertility with adoptive CD25+ natural killer cell transfer in sub-fertile NOD mice. Reprod Biomed Online 18 (2009) 95-103
24. Pradelles P., Grassi J., and Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 57 (1985) 1170-1173
25. Sharpe-Timms K.L. Using rats as a research model for the study of endometriosis. Ann N Y Acad Sci 955 (2002) 318-327
26. Grümmer R. Animals models in endometriosis research. Hum Reprod Update 5 (2006) 641-649
27. Ozawa Y., Murakami T., Tamura M., Terada Y., Yaegashi N., and Okamura K. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril 86 (2006) 1146-1151
28. Efstathiou J.A., Sampson D.A., Levine Z., Rohan R.M., Zurakowski D., Folkman J., et al. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril 83 (2005) 171-181
29. Laschke M.W., Elitzsch A., Scheuer C., Vollmar B., and Menger M.D. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 87 (2007) 163-171
30. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 (1992) 18-32
31. Siristatidis C., Nissotakis C., Chrelias C., Iacovidou H., and Salamalekis E. Immunological factors and their role in the genesis and development of endometriosis. J Obstet Gynaecol Res 32 (2006) 162-170
32. Lin Y.J., Lai M.D., Lei H.Y., and Wing L.Y. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 147 (2006) 1278-1286
33. Dionyssopoulou E., Vassiliadis S., Evangeliou A., Koumantakis E.E., and Athanassakis I. Constitutive or induced elevated levels of L-carnitine correlate with the cytokine and cellular profile of endometriosis. J Reprod Immunol 65 (2005) 159-170
34. McLaren J., Prentice A., Charnock-Jones D.S., Millican S.A., Müller K.H., Sharkey A.M., et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98 (1996) 482-489
35. Ceyhan S.T., Onguru O., Baser I., and Gunhan O. Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis. Fertil Steril 90 (2008) 988-993
36. Backer C.M., and D'Amato R.J. Angiogenesis and antiangiogenesis therapy in endometriosis. Microvasc Res 74 (2007) 121-130
37. Banu S.K., Lee J., Speights V.O., Starzinski-Powitz A., and Arosh J.A. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 149 (2008) 1180-1189
38. Banu S.K., Starzinski-Powitz A., Speights V.O., Burghardt R.C., and Arosh J.A. Induction of peritoneal endometriosis in nude mice with use of human immortalized endometriosis epithelial and stromal cells: a potential experimental tool to study molecular pathogenesis of endometriosis in humans. Fertil Steril 91 (2009) 2199-2209
39. Olivares C., Bilotas M., Buquet R., Borghi M., Sueldo C., Tesone M., et al. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 23 (2008) 2701-2708